rxstatShortages › Entacapone

Entacapone (Comtan) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 28, 2026

Some Entacapone products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A medication used together with levodopa to treat Parkinson's disease.

Products affected
1 / 5
In shortage since
Jun 24, 2026
Reports on file
27
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TEVA-ENTACAPONE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02375559 · since Jun 24, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Anticipated
MINT-ENTACAPONE
200MG · TABLET · MINT PHARMACEUTICALS INC
DIN 02535939 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Jun 1, 2026 · Delay in shipping of the drug.
Resolved
TEVA-ENTACAPONE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02375559 · ended Apr 15, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended May 26, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
TEVA-ENTACAPONE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02375559 · ended Aug 28, 2024 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Jul 22, 2024 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Dec 19, 2023 · Delay in shipping of the drug.
Resolved
TEVA-ENTACAPONE
200MG · TABLET · TEVA CANADA LIMITED
DIN 02375559 · ended Aug 3, 2023 · Disruption of the manufacture of the drug.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Apr 21, 2023 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Oct 19, 2022 · Requirements related to complying with good manufacturing practices.
Resolved
SANDOZ ENTACAPONE
200MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02380005 · ended Apr 28, 2022 · Requirements related to complying with good manufacturing practices.

Showing 12 of 27 reports. All reports are on file with Health Canada.

What's happening

Entacapone is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Entacapone is classified under “DOPAMINERGIC AGENTS” (ATC N04BX).

Recent changes

Common questions

What is Entacapone used for?

A medication used together with levodopa to treat Parkinson's disease.

When will Entacapone be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Entacapone in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (dopaminergic agents)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.